Literature DB >> 20148501

Evaluation and treatment of severe asymptomatic hypertension.

Chad S Kessler1, Yazen Joudeh.   

Abstract

Poorly controlled hypertension is a common finding in the outpatient setting. When patients present with severely elevated blood pressure (i.e., systolic blood pressure of 180 mm Hg or greater, or diastolic blood pressure of 110 mm Hg or greater), physicians need to differentiate hypertensive emergency from severely elevated blood pressure without signs or symptoms of end-organ damage (severe asymptomatic hypertension). Most patients who are asymptomatic but have poorly controlled hypertension do not have acute end-organ damage and, therefore, do not require immediate workup or treatment (within 24 hours). However, physicians should confirm blood pressure readings and appropriately classify the hypertensive state. A cardiovascular risk profile is important in guiding the treatment of severe asymptomatic hypertension; higher risk patients may benefit from more urgent and aggressive evaluation and treatment. Oral agents may be initiated before discharge, but intravenous medications and fast-acting oral agents should be reserved for true hypertensive emergencies. High blood pressure should be treated gradually. Appropriate, repeated follow-up over weeks to months is needed to reach desired blood pressure goals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148501

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  14 in total

Review 1.  Advances in management of acute hypertension: a concise review.

Authors:  David B Tulman; Stanislaw P A Stawicki; Thomas J Papadimos; Claire V Murphy; Sergio D Bergese
Journal:  Discov Med       Date:  2012-05       Impact factor: 2.970

2.  Retrospective review of the use of as-needed hydralazine and labetalol for the treatment of acute hypertension in hospitalized medicine patients.

Authors:  Michelle F Gaynor; Garth C Wright; Sheryl Vondracek
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01

3.  Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal.

Authors:  Surya Devkota; Raja Ram Dhungana; Achyut Raj Pandey; Bihungum Bista; Savyata Panthi; Kartikesh Kumar Thakur; Ratna Mani Gajurel
Journal:  Front Cardiovasc Med       Date:  2016-08-02

4.  Effects of Ramadan fasting on moderate to severe chronic kidney disease. A prospective observational study.

Authors:  Amaar A Bakhit; Amr M Kurdi; Junaid J Wadera; Abdulkareem O Alsuwaida
Journal:  Saudi Med J       Date:  2017-01       Impact factor: 1.484

5.  Hypertension treatment practices and its determinants among ambulatory patients: retrospective cohort study in Ethiopia.

Authors:  Derbew Fikadu Berhe; Katja Taxis; Flora M Haaijer-Ruskamp; Afework Mulugeta; Yewondwossen Tadesse Mengistu; Peter G M Mol
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

6.  Prevalence of Hypertension among Patients Attending Mobile Medical Clinics in the Philippines after Typhoon Haiyan.

Authors:  Linda Meta Mobula; Mary Lou Fisher; Nathan Lau; Abi Estelle; Tom Wood; William Plyler
Journal:  PLoS Curr       Date:  2016-12-20

7.  Screening, diagnosis, and long-term health outcomes in developing countries-The case of hypertension.

Authors:  Younoh Kim; Vlad Radoias
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

8.  Risk of vascular events in different manifestations of cerebral small vessel disease: A 2-year follow-up study with a control group.

Authors:  Jacek Staszewski; Renata Piusińska-Macoch; Bogdan Brodacki; Ewa Skrobowska; Katarzyna Macek; Adam Stępień
Journal:  Heliyon       Date:  2017-11-21

9.  Pharmacologic Treatment of Hypertensive Urgency in the Outpatient Setting: A Systematic Review.

Authors:  Claudia L Campos; Charles T Herring; Asima N Ali; Deanna N Jones; James L Wofford; Augustus L Caine; Robert L Bloomfield; Janine Tillett; Karen S Oles
Journal:  J Gen Intern Med       Date:  2018-01-16       Impact factor: 5.128

10.  Vascular parkinsonism and vascular dementia are associated with an increased risk of vascular events or death.

Authors:  Jacek Staszewski; Renata Piusińska-Macoch; Bogdan Brodacki; Ewa Skrobowska; Katarzyna Macek; Adam Stępień
Journal:  Arch Med Sci Atheroscler Dis       Date:  2017-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.